ALX Oncology Holdings Inc reports results for the quarter ended in June - Earnings Summary

ALX Oncology Holdings

10/08/2023 21:52

* ALX Oncology Holdings Inc  ALXO.OQ  reported a quarterly
adjusted loss of 84 cents​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 88 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ALX Oncology Holdings Inc's reported EPS for the quarter
was a
loss of 84 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ALX Oncology Holdings Inc shares had fallen by 33.6% this
quarter and lost 55.7% so far this year.
    * The company reported a quarterly loss of $34.16 million.
    * Wall Street's median 12-month price target for ALX
Oncology
Holdings Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 08:52 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.88          -0.84          Beat
 Mar. 31 2023      -0.80          -0.74          Beat
 Dec. 31 2022      -0.89          -0.75          Beat
 Sep. 30 2022      -0.77          -0.87          Missed